📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CytoSolv

1.1 - Company Overview

CytoSolv Logo

CytoSolv

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of wound care technology focused on the treatment of diabetic ulcers and other wounds, developing solutions aimed at curing diabetic ulcers.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CytoSolv

Universal Cells Logo

Universal Cells

HQ: United States Website
  • Description: Provider of nuclease-free rAAV gene editing technology to create universal donor pluripotent and engineered allogeneic stem cells, and cell production for clinical trials. Develops, licenses and commercializes stem cell therapies designed to overcome immune rejection and enable true off-the-shelf therapeutic products using a proprietary genome editing approach.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Universal Cells company profile →
Capstan Therapeutics Logo

Capstan Therapeutics

HQ: United States Website
  • Description: Provider of in vivo mRNA and gene-editing therapeutics powered by its proprietary CellSeeker targeted lipid nanoparticle (tLNP) platform that uses protein binders such as antibodies to deliver mRNA or gene-editing tools to specific cell types. Offerings include CPTX2309, an in vivo CAR-T candidate for autoimmune disorders, immune-cell engineering via mRNA-encoded CARs, and gene-editing delivery to pathogenic cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Capstan Therapeutics company profile →
OvaScience Logo

OvaScience

HQ: United States Website
  • Description: Provider of life sciences solutions focused on the discovery, development and commercialization of treatments for infertility.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OvaScience company profile →
Zelluna Logo

Zelluna

HQ: Norway Website
  • Description: Provider of TCR-based immunotherapies, developing off-the-shelf TCR-guided NK cell therapies for solid tumors. Pipeline includes a MAGE-A4 TCR-NK therapy for cancer advancing toward clinical trials, leveraging a wide range of TCRs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zelluna company profile →
Cellular Biomedicine Group Logo

Cellular Biomedicine Group

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical development focused on immunotherapies for cancers and stem cell therapies for degenerative diseases, utilizing proprietary cell therapy technologies built on thirty years of research and human treatment experience.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellular Biomedicine Group company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CytoSolv

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CytoSolv

2.2 - Growth funds investing in similar companies to CytoSolv

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CytoSolv

4.2 - Public trading comparable groups for CytoSolv

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CytoSolv

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CytoSolv

What does CytoSolv do?

CytoSolv is a provider of wound care technology focused on the treatment of diabetic ulcers and other wounds, developing solutions aimed at curing diabetic ulcers.

Who are CytoSolv's competitors?

CytoSolv's competitors and similar companies include Universal Cells, Capstan Therapeutics, OvaScience, Zelluna, and Cellular Biomedicine Group.

Where is CytoSolv headquartered?

CytoSolv is headquartered in United States.

How many employees does CytoSolv have?

CytoSolv has 1,000 employees 🔒.

When was CytoSolv founded?

CytoSolv was founded in 2010 🔒.

What sector and industry vertical is CytoSolv in?

CytoSolv is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CytoSolv

Who are the top strategic acquirers in CytoSolv's sector and industry

Top strategic M&A buyers and acquirers in CytoSolv's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CytoSolv?

Top strategic M&A buyers groups and sectors for CytoSolv include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CytoSolv's sector and industry vertical

Which are the top PE firms investing in CytoSolv's sector and industry vertical?

Top PE firms investing in CytoSolv's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CytoSolv's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CytoSolv's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CytoSolv's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CytoSolv include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CytoSolv's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CytoSolv?

The key public trading comparables and valuation benchmarks for CytoSolv include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CytoSolv for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CytoSolv with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CytoSolv's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CytoSolv with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CytoSolv's' sector and industry vertical?

Access recent funding rounds and capital raises in CytoSolv's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CytoSolv